{"id":6544,"date":"2022-09-27T06:00:00","date_gmt":"2022-09-27T06:00:00","guid":{"rendered":"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar\/"},"modified":"2022-09-27T06:00:00","modified_gmt":"2022-09-27T06:00:00","slug":"nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar","status":"publish","type":"mfn_news","link":"https:\/\/nanexa.com\/sv\/mfn_news\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar\/","title":{"rendered":"Nanexa AB och Vitrivax, Inc har n\u00e5tt en \u00f6verenskommelse i alla v\u00e4sentliga delar"},"content":{"rendered":"<div class=\"mfn-preamble\">\n<p><strong>Nanexa AB och Vitrivax, Inc. har idag givit in en skrivelse d\u00e4r de beg\u00e4r att Nanexas st\u00e4mning avseende patentintr\u00e5ng vid domstolen i Delaware f\u00f6rklaras vilande i avvaktan p\u00e5 att parterna finaliserar villkoren f\u00f6r en f\u00f6rlikning som man i allt v\u00e4sentligt redan kommit \u00f6verens om.<\/strong><\/p>\n<\/div>\n<div class=\"mfn-body\">\n<\/div>\n<div class=\"mfn-footer mfn-contacts mfn-2376405b3437\">\n<p><strong class=\"mfn-heading-1\">F\u00f6r mer information kontakta:<\/strong><\/p>\n<hr \/>\n<p>David Westberg \u2013 VD, Nanexa AB (publ)\u00a0<br \/>Telefon: 0709-42 83 03<br \/>E-post:\u00a0<a href=\"mailto:david.westberg@nanexa.se\" target=\"_blank\" rel=\"nofollow noopener\">david.westberg@nanexa.se<\/a><br \/><a target=\"_blank\" href=\"http:\/\/www.nanexa.com\" rel=\"nofollow noopener\">www.nanexa.com<\/a><\/p>\n<p>Erik Penser Bank \u00e4r bolagets Certified Adviser och n\u00e5s p\u00e5 08-463 83 00, e-post: certifiedadviser@penser.se<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-about mfn-c9ba281e2dde\">\n<p><strong class=\"mfn-heading-1\">Om Nanexa AB (publ)<\/strong><\/p>\n<hr \/>\n<p>Nanexa \u00e4r ett l\u00e4kemedelsbolag som utvecklar parenterala l\u00e4kemedel baserade p\u00e5 det patenterade och innovativa drug delivery-systemet PharmaShell\u00ae \u2013 ett system som m\u00f6jligg\u00f6r n\u00e4sta generations l\u00e5ngverkande injicerbara l\u00e4kemedel med h\u00f6g drug load, tillverkade med atomlagerprecision. Nanexa utvecklar egna produkter och har dessutom samarbetsavtal med flera l\u00e4kemedelsbolag, d\u00e4ribland AstraZeneca.<\/p>\n<p>Nanexas aktie \u00e4r noterad p\u00e5 Nasdaq First North Growth Market i Stockholm (NANEXA).<\/p>\n<\/div>\n<div class=\"mfn-footer mfn-attachment mfn-attachment-general\">\n<p><strong class=\"mfn-heading-1\">Bifogade filer<\/strong><\/p>\n<hr \/>\n<p><a class=\"mfn-generated mfn-primary\" href=\"https:\/\/storage.mfn.se\/e86c0fb1-f6f3-4174-bc7f-7461628ccce3\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar.pdf\" target=\"_blank\" rel=\"nofollow noopener\">Nanexa AB och Vitrivax, Inc har n\u00e5tt en \u00f6verenskommelse i alla v\u00e4sentliga delar<\/a><\/p>\n<\/div>\n","protected":false},"excerpt":{"rendered":"<p>Nanexa AB och Vitrivax, Inc. har idag givit in en skrivelse d\u00e4r de beg\u00e4r att Nanexas st\u00e4mning avseende patentintr\u00e5ng vid domstolen i Delaware f\u00f6rklaras vilande i avvaktan p\u00e5 att parterna finaliserar villkoren f\u00f6r en f\u00f6rlikning som man i allt v\u00e4sentligt redan kommit \u00f6verens om.<\/p>\n","protected":false},"template":"","class_list":["post-6544","mfn_news","type-mfn_news","status-publish","hentry","mfn-news-tag-mfn-ci_sv","mfn-news-tag-mfn-type-ir_sv","mfn-news-tag-mfn_sv","mfn-news-tag-mfn-ci-other_sv","mfn-news-tag-mfn-lang-sv_sv"],"acf":[],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.4 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>Nanexa AB och Vitrivax, Inc har n\u00e5tt en \u00f6verenskommelse i alla v\u00e4sentliga delar - Nanexa AB<\/title>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar\/\" \/>\n<meta property=\"og:locale\" content=\"sv_SE\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"Nanexa AB och Vitrivax, Inc har n\u00e5tt en \u00f6verenskommelse i alla v\u00e4sentliga delar - Nanexa AB\" \/>\n<meta property=\"og:description\" content=\"Nanexa AB och Vitrivax, Inc. har idag givit in en skrivelse d\u00e4r de beg\u00e4r att Nanexas st\u00e4mning avseende patentintr\u00e5ng vid domstolen i Delaware f\u00f6rklaras vilande i avvaktan p\u00e5 att parterna finaliserar villkoren f\u00f6r en f\u00f6rlikning som man i allt v\u00e4sentligt redan kommit \u00f6verens om.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar\/\" \/>\n<meta property=\"og:site_name\" content=\"Nanexa AB\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:label1\" content=\"Ber\u00e4knad l\u00e4stid\" \/>\n\t<meta name=\"twitter:data1\" content=\"1 minut\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar\\\/\",\"name\":\"Nanexa AB och Vitrivax, Inc har n\u00e5tt en \u00f6verenskommelse i alla v\u00e4sentliga delar - Nanexa AB\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\"},\"datePublished\":\"2022-09-27T06:00:00+00:00\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar\\\/#breadcrumb\"},\"inLanguage\":\"sv-SE\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar\\\/\"]}]},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Hem\",\"item\":\"https:\\\/\\\/nanexa.com\\\/sv\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"MFN News Items\",\"item\":\"https:\\\/\\\/nanexa.com\\\/mfn_news\\\/\"},{\"@type\":\"ListItem\",\"position\":3,\"name\":\"Nanexa AB och Vitrivax, Inc har n\u00e5tt en \u00f6verenskommelse i alla v\u00e4sentliga delar\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#website\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"name\":\"Nanexa AB\",\"description\":\"\",\"publisher\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/nanexa.com\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"sv-SE\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#organization\",\"name\":\"Nanexa AB\",\"url\":\"https:\\\/\\\/nanexa.com\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"sv-SE\",\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"contentUrl\":\"https:\\\/\\\/nanexa.com\\\/wp-content\\\/uploads\\\/2015\\\/04\\\/nanexa-logo.png\",\"width\":165,\"height\":50,\"caption\":\"Nanexa AB\"},\"image\":{\"@id\":\"https:\\\/\\\/nanexa.com\\\/#\\\/schema\\\/logo\\\/image\\\/\"}}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"Nanexa AB och Vitrivax, Inc har n\u00e5tt en \u00f6verenskommelse i alla v\u00e4sentliga delar - Nanexa AB","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar\/","og_locale":"sv_SE","og_type":"article","og_title":"Nanexa AB och Vitrivax, Inc har n\u00e5tt en \u00f6verenskommelse i alla v\u00e4sentliga delar - Nanexa AB","og_description":"Nanexa AB och Vitrivax, Inc. har idag givit in en skrivelse d\u00e4r de beg\u00e4r att Nanexas st\u00e4mning avseende patentintr\u00e5ng vid domstolen i Delaware f\u00f6rklaras vilande i avvaktan p\u00e5 att parterna finaliserar villkoren f\u00f6r en f\u00f6rlikning som man i allt v\u00e4sentligt redan kommit \u00f6verens om.","og_url":"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar\/","og_site_name":"Nanexa AB","twitter_card":"summary_large_image","twitter_misc":{"Ber\u00e4knad l\u00e4stid":"1 minut"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"WebPage","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar\/","url":"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar\/","name":"Nanexa AB och Vitrivax, Inc har n\u00e5tt en \u00f6verenskommelse i alla v\u00e4sentliga delar - Nanexa AB","isPartOf":{"@id":"https:\/\/nanexa.com\/#website"},"datePublished":"2022-09-27T06:00:00+00:00","breadcrumb":{"@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar\/#breadcrumb"},"inLanguage":"sv-SE","potentialAction":[{"@type":"ReadAction","target":["https:\/\/nanexa.com\/mfn_news\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar\/"]}]},{"@type":"BreadcrumbList","@id":"https:\/\/nanexa.com\/mfn_news\/nanexa-ab-och-vitrivax-inc-har-natt-en-overenskommelse-i-alla-vasentliga-delar\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Hem","item":"https:\/\/nanexa.com\/sv\/"},{"@type":"ListItem","position":2,"name":"MFN News Items","item":"https:\/\/nanexa.com\/mfn_news\/"},{"@type":"ListItem","position":3,"name":"Nanexa AB och Vitrivax, Inc har n\u00e5tt en \u00f6verenskommelse i alla v\u00e4sentliga delar"}]},{"@type":"WebSite","@id":"https:\/\/nanexa.com\/#website","url":"https:\/\/nanexa.com\/","name":"Nanexa AB","description":"","publisher":{"@id":"https:\/\/nanexa.com\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/nanexa.com\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"sv-SE"},{"@type":"Organization","@id":"https:\/\/nanexa.com\/#organization","name":"Nanexa AB","url":"https:\/\/nanexa.com\/","logo":{"@type":"ImageObject","inLanguage":"sv-SE","@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/","url":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","contentUrl":"https:\/\/nanexa.com\/wp-content\/uploads\/2015\/04\/nanexa-logo.png","width":165,"height":50,"caption":"Nanexa AB"},"image":{"@id":"https:\/\/nanexa.com\/#\/schema\/logo\/image\/"}}]}},"_links":{"self":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news\/6544","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/mfn_news"}],"about":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/types\/mfn_news"}],"wp:attachment":[{"href":"https:\/\/nanexa.com\/sv\/wp-json\/wp\/v2\/media?parent=6544"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}